Human Subcutaneous Inflammatory Response to Glucose Sensors

NCT05755243 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2023-09-28

No results posted yet for this study

Summary

The aim of the study is to describe the inflammatory response to enzimatic glucose sensors after 10 days of use and to evaluate the relationship between the magnitude of the FBR (foreign body response) with the accuracy of the sensor (MARD)

Conditions

  • Inflammatory Response to Glucose Sensors

Interventions

DEVICE

glucose sensor

skin biopsy (punch)

Sponsors & Collaborators

  • Corporacion Parc Tauli

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-21
Primary Completion
2023-07-12
Completion
2023-09-20
FDA Device
Yes

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05755243 on ClinicalTrials.gov